Suppr超能文献

硼替佐米具有强大的抗肿瘤和抗血管生成活性。

Boromycin Has Potent Anti- and Anti- Activity.

机构信息

Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.

College of Veterinary Science and Medicine, Central Luzon State University, Science City of Muñoz, Nueva Ecija, Philippines.

出版信息

Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.01278-20.

Abstract

and , members of the phylum Apicomplexa, are significant pathogens of both humans and animals worldwide for which new and effective therapeutics are needed. Here, we describe the activity of the antibiotic boromycin against and Boromycin potently inhibited intracellular proliferation of both and at half-maximal effective concentrations (EC) of 2.27 nM and 4.99 nM, respectively. Treatment of extracellular tachyzoites with 25 nM boromycin for 30 min suppressed 84% of parasite growth, but tachyzoite invasion into host cells was not affected by boromycin. Immunofluorescence of boromycin-treated showed loss of morphologically intact parasites with randomly distributed surface antigens inside the parasitophorous vacuoles. Boromycin exhibited a high selectivity for the parasites over their host cells. These results suggest that boromycin is a promising new drug candidate for treating toxoplasmosis and cryptosporidiosis.

摘要

并且,门顶复体纲的成员,是全球范围内人类和动物的重要病原体,需要新的和有效的治疗方法。在这里,我们描述了抗生素硼霉素对和的活性。硼霉素对和的半数有效浓度(EC)分别为 2.27 nM 和 4.99 nM,强烈抑制了这两种寄生虫的细胞内增殖。用 25 nM 的硼霉素处理 30 分钟,可抑制 84%的寄生虫生长,但硼霉素不会影响速殖子侵入宿主细胞。硼霉素处理后的免疫荧光显示,形态完整的寄生虫丢失,寄生空泡内的表面抗原随机分布。硼霉素对寄生虫表现出很高的选择性,而对其宿主细胞则没有。这些结果表明,硼霉素是一种很有前途的治疗弓形虫病和隐孢子虫病的新药候选物。

相似文献

1
Boromycin Has Potent Anti- and Anti- Activity.
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.01278-20.
2
Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum.
Int J Parasitol Drugs Drug Resist. 2022 Aug;19:6-20. doi: 10.1016/j.ijpddr.2022.04.001. Epub 2022 Apr 16.
3
Novel acyl carbamates and acyl / diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum.
Int J Parasitol Drugs Drug Resist. 2020 Dec;14:80-90. doi: 10.1016/j.ijpddr.2020.08.006. Epub 2020 Aug 25.
4
In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against .
Int J Mol Sci. 2022 Aug 24;23(17):9586. doi: 10.3390/ijms23179586.
5
Nullscript inhibits Cryptosporidium and Toxoplasma growth.
Int J Parasitol Drugs Drug Resist. 2020 Dec;14:159-166. doi: 10.1016/j.ijpddr.2020.10.004. Epub 2020 Oct 15.
6
Stable expression of mucin glycoproteins GP40 and GP15 of Cryptosporidium parvum in Toxoplasma gondii.
Parasit Vectors. 2024 Feb 15;17(1):65. doi: 10.1186/s13071-024-06159-y.
8
Targeted Phenotypic Screening in and Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules.
mSphere. 2018 Jan 17;3(1). doi: 10.1128/mSphere.00534-17. eCollection 2018 Jan-Feb.
9
Apicomplexan infections in the gut.
Parasite Immunol. 2014 Sep;36(9):409-20. doi: 10.1111/pim.12115.
10
In situ ultrastructures of two evolutionarily distant apicomplexan rhoptry secretion systems.
Nat Commun. 2021 Aug 17;12(1):4983. doi: 10.1038/s41467-021-25309-9.

引用本文的文献

2
Tartrolon E rapidly blocks Toxoplasma gondii capacity to invade host cells.
Int J Parasitol Drugs Drug Resist. 2025 Apr 14;28:100591. doi: 10.1016/j.ijpddr.2025.100591.
3
Activity of Organoboron Compounds against Biofilm-Forming Pathogens.
Antibiotics (Basel). 2024 Sep 29;13(10):929. doi: 10.3390/antibiotics13100929.
4
Construction of luciferase-expressing Neospora caninum and drug screening.
Parasit Vectors. 2024 Mar 8;17(1):118. doi: 10.1186/s13071-024-06195-8.
5
Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.
Microbiol Spectr. 2023 Feb 14;11(1):e0387422. doi: 10.1128/spectrum.03874-22. Epub 2022 Dec 19.
6
Diagnosis and control of cryptosporidiosis in farm animals.
J Parasit Dis. 2022 Dec;46(4):1133-1146. doi: 10.1007/s12639-022-01513-2. Epub 2022 Jul 4.
8
Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of .
Front Cell Infect Microbiol. 2022 Jan 14;11:802294. doi: 10.3389/fcimb.2021.802294. eCollection 2021.

本文引用的文献

1
A symbiotic bacterium of shipworms produces a compound with broad spectrum anti-apicomplexan activity.
PLoS Pathog. 2020 May 26;16(5):e1008600. doi: 10.1371/journal.ppat.1008600. eCollection 2020 May.
2
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis.
Nat Commun. 2019 Jun 27;10(1):2816. doi: 10.1038/s41467-019-10687-y.
3
Chemotherapeutic Potential of Monensin as an Anti-microbial Agent.
Curr Top Med Chem. 2018;18(22):1976-1986. doi: 10.2174/1568026619666181129141151.
4
High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth.
Int J Parasitol Drugs Drug Resist. 2018 Apr;8(1):137-144. doi: 10.1016/j.ijpddr.2018.02.002. Epub 2018 Feb 16.
5
Drug Repurposing Screening Identifies Novel Compounds That Effectively Inhibit Toxoplasma gondii Growth.
mSphere. 2016 Mar 2;1(2). doi: 10.1128/mSphere.00042-15. eCollection 2016 Mar-Apr.
6
Boromycin Kills Mycobacterial Persisters without Detectable Resistance.
Front Microbiol. 2016 Feb 22;7:199. doi: 10.3389/fmicb.2016.00199. eCollection 2016.
7
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.
Nature. 2015 Jul 23;523(7561):477-80. doi: 10.1038/nature14651. Epub 2015 Jul 15.
8
Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.
Antimicrob Agents Chemother. 2015 Sep;59(9):5135-44. doi: 10.1128/AAC.04332-14. Epub 2015 Jun 8.
9
Congenital Toxoplasmosis.
J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1(Suppl 1):S30-5. doi: 10.1093/jpids/piu077.
10
Drug repurposing and human parasitic protozoan diseases.
Int J Parasitol Drugs Drug Resist. 2014 Mar 24;4(2):95-111. doi: 10.1016/j.ijpddr.2014.02.002. eCollection 2014 Aug.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验